IgniteData, a leader in intelligent clinical trial data automation, and ICHTYS Technology SA (ICHTYS), a leader in clinical research technology, today announced a new partnership which will make IgniteData’s Archer platform available to the ICHTYS network of supported clinical research centers across Latin America, providing them with new technology and tools to securely and efficiently transfer clinical data. The partnership will also extend to ICHTYS ongoing expansion into additional major global clinical trial markets, including in the U.S. and Europe.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112784595/en/

Since its launch in 2020, ICHTYS’ comprehensive cloud-based platform, Alpha-CR, has helped to transform how clinical research is done in Latin America. The platform simplifies and optimizes every aspect of clinical trial management, spanning CTMS, validated eSource, eRegulatory, eFinance, medication stock and dispensing management, and patient recruitment, into a single, easy to use system. The platform is currently utilized by more than 60 sites across Latin America, including in Argentina, Chile, and Mexico, supporting studies by a multitude of global pharmaceutical sponsors and industry leading contract research organizations.

Created by IgniteData, Archer is the only platform built from the ground up solely to solve for long-standing data transfer challenges and is the only platform compatible with every data collection tool used today by sites and sponsors. IgniteData is engaged at 80% of the National Cancer Institute’s Designated Cancer Centers, including 19 of the top 30 cancer centers in the U.S. The company’s site network spans four continents, six countries, and 11 international institutions, with a 100% retention rate among its partners.

For research sites utilizing Alpha-CR, this agreement will allow them to leverage Archer to transfer clinical data of any type from Alpha-CR directly to the clinical trial sponsor’s electronic data capture (EDC) or other sponsor data destination of choice. Utilizing Archer has been proven to significantly streamline the time spent by research centers on data acquisition and monitoring, allowing them to improve their efficiency in clinical research at scale, reduce administrative costs, and enable staff to redirect their time towards more valuable, patient-focused activities. For trial sponsors, utilizing the Archer platform can help reduce clinical development timelines, allowing them to focus their budget on more meaningful clinical trial activities, and potentially shorten their runway to commercialization.

“ICHTYS has established a clear leadership position in Latin America and has played a pivotal role in rapidly establishing the region as a sought-after location for global clinical trials,” said Carson Goff, Vice President of Strategic Accounts at IgniteData. “Helping sponsors to move clinical data more quickly and efficiently means being available and accessible to them in every part of the globe that they are conducting clinical trials. We can think of no better partner for us to fulfill this mission in Latin America than ICHTYS and we are excited to expand this partnership to additional key global markets moving forward.”

“Global clinical research location trends clearly show that when equipped with the right technology, Latin America can compete with any market in the world and at the highest international standards,” said Nicolás Daguerre, Co-Founder and Chief Executive Officer of ICHTYS. “We are thrilled at the opportunity to partner with IgniteData to provide sites in Latin America and beyond with cutting-edge technology to help them work more efficiently and advance important clinical research more quickly.”

As an initial focus of the partnership, ICHTYS and IgniteData will launch the Archer platform at CINME, one of Argentina’s leading clinical research centers which has ongoing clinical trial partnerships with more than 30 global pharmaceutical companies. The platform will be used to support a range of current and planned studies focused on new treatments for cardiometabolic diseases.

“CINME is proud to be playing an increasingly larger and international role in the development of groundbreaking treatments for conditions like diabetes and obesity,” said Dr. Federico Pérez Manghi, President of CINME. “Our work is being supported by world-class scientific talent here in Argentina and we relish the opportunity to apply cutting-edge technologies like Alpha-CR and Archer to enable our teams to spend less time on administrative tasks and more time on science and patient care.”

Representatives from IgniteData and ICHTYS will be at the 2026 Latin American Site Solutions Summit, hosted by the Society for Clinical Research Sites (SCRS) taking place November 16-17, 2026, in Buenos Aires, Argentina, to demonstrate the companies’ new joint clinical trial data capabilities and connections. Conference attendees interested in learning more can visit booths 16 and 17 for additional details.

About IgniteData

IgniteData is on a mission to revolutionize clinical trials through intelligent automation. By enabling real-time, secure transfer of clinical data between sites and sponsors, IgniteData accelerates research while reducing burden on clinical sites. IgniteData’s Archer is a 100% agnostic technology that allows for deployments across premier research centers and top pharmaceutical sponsors. By minimizing manual errors, reducing data discrepancies, and limiting downstream queries, IgniteData’s Archer improves data quality, accelerates study timelines, and allows teams to focus on advancing research and delivering better patient outcomes faster.

About ICHTYS Technology SA

ICHTYS Technology SA is a health technology company dedicated to transforming clinical research through innovative, secure, and integrated digital solutions. Its comprehensive platform streamlines clinical trial management, electronic health records, data collection, and regulatory processes, improving efficiency, traceability, and data quality. ISO 27001 certified and aligned with international regulatory standards, ICHTYS combines technological innovation with a human-centered approach to advance safer, smarter, and more efficient clinical research.

About CINME

CINME is a leading clinical research center in Argentina, dedicated to advancing medical science through high-quality clinical trials and patient-centered care. With extensive experience across multiple therapeutic areas, a multidisciplinary team, and advanced research infrastructure, CINME collaborates with pharmaceutical sponsors and research organizations to conduct studies under international quality and ethical standards. Its commitment to innovation, operational excellence, and patient safety contributes to the development of new treatments and better healthcare outcomes.

Media gallery

About The Author
Business Wire